Tracking the incidence of COVID-19 globally, it is understood that people over the age of 60 with a pre-existing chronic condition, such as cardiovascular disease (CVD) or diabetes, are considered at greater risk to serious infection and complications.1 There has been a high prevalence of CVD in those dying from COVID-19 in Italy and China, two of the worst…

Read More

Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…

Read More

This World Sleep Day, VIVA! partnered with GenesisCare outlining new research that linked just one night’s lost sleep to increased risk of Alzheimer’s Disease. This research highlights the urgent need for Australian’s to improve their sleep hygiene. The research, recently published in Neurology Journal, reinforces the strong link between lack of sleep and increased levels…

Read More

Imagine waking up each morning with a tight chest, burning throat and a smoke-choked city cloaking the sun, with air quality levels measuring ‘extremely hazardous’. This is the situation we are currently facing in Australia, and those of us fortunate enough to live in metropolitan areas, are the lucky ones. Although not yet half-way through…

Read More

Young Singaporean adults aged 18-34 are most at risk of developing a mental health illness, a Singapore Mental Health Study has found. A report on the findings, released on Tuesday this week, showed individuals in that age group were most likely to have experienced bipolar disorder, major depressive disorder, alcohol abuse, and obsessive compulsive disorder.…

Read More